Correlation Between General Cannabis and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both General Cannabis and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining General Cannabis and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Cannabis Corp and Cannara Biotech, you can compare the effects of market volatilities on General Cannabis and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in General Cannabis with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of General Cannabis and Cannara Biotech.

Diversification Opportunities for General Cannabis and Cannara Biotech

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between General and Cannara is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding General Cannabis Corp and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and General Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Cannabis Corp are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of General Cannabis i.e., General Cannabis and Cannara Biotech go up and down completely randomly.

Pair Corralation between General Cannabis and Cannara Biotech

Given the investment horizon of 90 days General Cannabis Corp is expected to under-perform the Cannara Biotech. In addition to that, General Cannabis is 1.6 times more volatile than Cannara Biotech. It trades about -0.11 of its total potential returns per unit of risk. Cannara Biotech is currently generating about 0.0 per unit of volatility. If you would invest  53.00  in Cannara Biotech on September 1, 2024 and sell it today you would lose (2.00) from holding Cannara Biotech or give up 3.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

General Cannabis Corp  vs.  Cannara Biotech

 Performance 
       Timeline  
General Cannabis Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days General Cannabis Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Cannara Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

General Cannabis and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with General Cannabis and Cannara Biotech

The main advantage of trading using opposite General Cannabis and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if General Cannabis position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind General Cannabis Corp and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance